ARTICLE | Distillery Therapeutics
Cancer
October 24, 2017 6:59 PM UTC
Cell culture studies identified a fucose-based TSTA3 inhibitor that could help treat hepatoma. In cell-based activity assays, a previously identified fucose analog inhibited TSTA3 activity with a Ki o...
BCIQ Company Profiles
National Institute of Physical and Chemical Research (Riken)
BCIQ Target Profiles